Fig. 9From: Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular CarcinomaZBTB9 related 7 genes prognostic and immunity-relation analyses. The Kaplan–Meier survival curves of CUTA (A). KCTD20 (B), NFYA (C), RPL7L1 (D), SLC39A7 (E), TAF11 (F), WDR46 (G)Back to article page